MEDIC — Medicon Hellas SA Cashflow Statement
0.000.00%
- €10.61m
- €11.79m
- €18.12m
- 71
- 93
- 45
- 84
Annual cashflow statement for Medicon Hellas SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.45 | 4.78 | 3.66 | 1.67 | 1.55 |
Depreciation | |||||
Non-Cash Items | 0.256 | 0.634 | -0.545 | 0.239 | 0.146 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.044 | -2.31 | -3.49 | -2.73 | -1.45 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3.07 | 4.79 | 1.25 | 0.878 | 2 |
Capital Expenditures | -0.735 | -0.554 | -0.408 | -1.59 | -1.01 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.239 | 0.239 | 0.193 | 0.611 | 0.607 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.495 | -0.316 | -0.215 | -0.984 | -0.398 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.45 | -1.32 | -1.18 | -1.64 | -1.55 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.13 | 3.16 | -0.148 | -1.75 | 0.048 |